Statistics
Publications
11
Citations
4.8K
H-Index
10
Active since
2010
Jeffrey Cehelsky is an author at Alnylam Pharmaceuticals (United States) specializing in life sciences, rna interference, and gene therapy.
Publications per year
2010–2022
11
11
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D. Gillmore, Ed Gane, Jörg Täubel et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho, David Adams, Ana Silva et al. · New England Journal of Medicine · 2013 · 961 citations · Full text
Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya et al. · The Lancet · 2013 · 574 citations
John P. DeVincenzo, Rob Lambkin‐Williams, Tom Wilkinson et al. · Proceedings of the National Academy of Sciences · 2010 · 439 citations · Full text
1–5 of 11